vs

Side-by-side financial comparison of EZCORP INC (EZPW) and MYRIAD GENETICS INC (MYGN). Click either name above to swap in a different company.

EZCORP INC is the larger business by last-quarter revenue ($382.0M vs $209.8M, roughly 1.8× MYRIAD GENETICS INC). On growth, EZCORP INC posted the faster year-over-year revenue change (19.3% vs -0.4%). Over the past eight quarters, EZCORP INC's revenue compounded faster (15.6% CAGR vs 1.9%).

EZCORP, Inc. is an American pawn shop operator based in Austin, Texas which provides services across the United States and Latin America. It is a publicly traded company listed on the NASDAQ stock exchange and is the second largest pawn shop operator in the U.S. after Cash America International.

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

EZPW vs MYGN — Head-to-Head

Bigger by revenue
EZPW
EZPW
1.8× larger
EZPW
$382.0M
$209.8M
MYGN
Growing faster (revenue YoY)
EZPW
EZPW
+19.7% gap
EZPW
19.3%
-0.4%
MYGN
Faster 2-yr revenue CAGR
EZPW
EZPW
Annualised
EZPW
15.6%
1.9%
MYGN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
EZPW
EZPW
MYGN
MYGN
Revenue
$382.0M
$209.8M
Net Profit
$44.3M
Gross Margin
58.4%
70.0%
Operating Margin
15.9%
-2.7%
Net Margin
11.6%
Revenue YoY
19.3%
-0.4%
Net Profit YoY
42.8%
EPS (diluted)
$0.55
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EZPW
EZPW
MYGN
MYGN
Q4 25
$382.0M
$209.8M
Q3 25
$336.8M
$205.7M
Q2 25
$311.0M
$213.1M
Q1 25
$306.3M
$195.9M
Q4 24
$320.2M
$210.6M
Q3 24
$294.6M
$213.3M
Q2 24
$281.4M
$211.5M
Q1 24
$285.6M
$202.2M
Net Profit
EZPW
EZPW
MYGN
MYGN
Q4 25
$44.3M
Q3 25
$26.7M
$-27.4M
Q2 25
$26.5M
$-330.5M
Q1 25
$25.4M
$-100.0K
Q4 24
$31.0M
Q3 24
$15.2M
$-22.1M
Q2 24
$17.9M
$-36.7M
Q1 24
$21.5M
$-26.0M
Gross Margin
EZPW
EZPW
MYGN
MYGN
Q4 25
58.4%
70.0%
Q3 25
59.0%
69.9%
Q2 25
59.1%
71.2%
Q1 25
58.3%
68.5%
Q4 24
57.9%
71.7%
Q3 24
59.5%
70.2%
Q2 24
59.2%
69.6%
Q1 24
58.7%
68.1%
Operating Margin
EZPW
EZPW
MYGN
MYGN
Q4 25
15.9%
-2.7%
Q3 25
11.0%
-11.3%
Q2 25
11.6%
-154.5%
Q1 25
11.2%
-14.8%
Q4 24
13.1%
-18.6%
Q3 24
8.8%
-9.4%
Q2 24
7.9%
-17.3%
Q1 24
9.6%
-13.8%
Net Margin
EZPW
EZPW
MYGN
MYGN
Q4 25
11.6%
Q3 25
7.9%
-13.3%
Q2 25
8.5%
-155.1%
Q1 25
8.3%
-0.1%
Q4 24
9.7%
Q3 24
5.2%
-10.4%
Q2 24
6.4%
-17.4%
Q1 24
7.5%
-12.9%
EPS (diluted)
EZPW
EZPW
MYGN
MYGN
Q4 25
$0.55
$-0.09
Q3 25
$0.35
$-0.29
Q2 25
$0.34
$-3.57
Q1 25
$0.33
$0.00
Q4 24
$0.40
$-0.47
Q3 24
$0.20
$-0.24
Q2 24
$0.25
$-0.41
Q1 24
$0.29
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EZPW
EZPW
MYGN
MYGN
Cash + ST InvestmentsLiquidity on hand
$465.9M
$149.6M
Total DebtLower is stronger
$518.6M
$119.9M
Stockholders' EquityBook value
$1.1B
$368.0M
Total Assets
$2.0B
$706.6M
Debt / EquityLower = less leverage
0.48×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EZPW
EZPW
MYGN
MYGN
Q4 25
$465.9M
$149.6M
Q3 25
$469.5M
$145.4M
Q2 25
$472.1M
$74.4M
Q1 25
$505.2M
$91.8M
Q4 24
$174.5M
$102.4M
Q3 24
$170.5M
$99.9M
Q2 24
$218.0M
$97.3M
Q1 24
$229.1M
$104.3M
Total Debt
EZPW
EZPW
MYGN
MYGN
Q4 25
$518.6M
$119.9M
Q3 25
$518.1M
$119.5M
Q2 25
$517.6M
Q1 25
$620.5M
Q4 24
$327.7M
Q3 24
$327.3M
Q2 24
$361.3M
Q1 24
$360.9M
Stockholders' Equity
EZPW
EZPW
MYGN
MYGN
Q4 25
$1.1B
$368.0M
Q3 25
$1.0B
$372.8M
Q2 25
$990.1M
$388.1M
Q1 25
$851.6M
$704.9M
Q4 24
$823.9M
$701.1M
Q3 24
$804.6M
$731.7M
Q2 24
$801.5M
$740.5M
Q1 24
$800.4M
$760.0M
Total Assets
EZPW
EZPW
MYGN
MYGN
Q4 25
$2.0B
$706.6M
Q3 25
$2.0B
$728.1M
Q2 25
$1.9B
$677.3M
Q1 25
$1.8B
$1.0B
Q4 24
$1.5B
$1.0B
Q3 24
$1.5B
$1.1B
Q2 24
$1.5B
$1.1B
Q1 24
$1.5B
$1.1B
Debt / Equity
EZPW
EZPW
MYGN
MYGN
Q4 25
0.48×
0.33×
Q3 25
0.51×
0.32×
Q2 25
0.52×
Q1 25
0.73×
Q4 24
0.40×
Q3 24
0.41×
Q2 24
0.45×
Q1 24
0.45×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EZPW
EZPW
MYGN
MYGN
Operating Cash FlowLast quarter
$39.1M
$10.6M
Free Cash FlowOCF − Capex
$31.7M
FCF MarginFCF / Revenue
8.3%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$121.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EZPW
EZPW
MYGN
MYGN
Q4 25
$39.1M
$10.6M
Q3 25
$51.3M
$21.1M
Q2 25
$34.8M
$-13.6M
Q1 25
$36.9M
$-16.3M
Q4 24
$26.0M
$6.6M
Q3 24
$43.3M
$700.0K
Q2 24
$33.7M
$2.6M
Q1 24
$15.1M
$-18.6M
Free Cash Flow
EZPW
EZPW
MYGN
MYGN
Q4 25
$31.7M
Q3 25
$35.7M
Q2 25
$25.7M
Q1 25
$28.6M
Q4 24
$20.4M
Q3 24
$24.4M
Q2 24
$30.5M
Q1 24
$8.6M
FCF Margin
EZPW
EZPW
MYGN
MYGN
Q4 25
8.3%
Q3 25
10.6%
Q2 25
8.3%
Q1 25
9.3%
Q4 24
6.4%
Q3 24
8.3%
Q2 24
10.8%
Q1 24
3.0%
Capex Intensity
EZPW
EZPW
MYGN
MYGN
Q4 25
2.0%
Q3 25
4.6%
Q2 25
2.9%
Q1 25
2.7%
Q4 24
1.8%
Q3 24
6.4%
Q2 24
1.1%
Q1 24
2.3%
Cash Conversion
EZPW
EZPW
MYGN
MYGN
Q4 25
0.88×
Q3 25
1.92×
Q2 25
1.31×
Q1 25
1.45×
Q4 24
0.84×
Q3 24
2.85×
Q2 24
1.88×
Q1 24
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EZPW
EZPW

Merchandise$210.1M55%
Pawn Service$131.9M35%
Jewelry Scrap$39.9M10%

MYGN
MYGN

Segment breakdown not available.

Related Comparisons